299 BASELINE CHARACTERISTICS ASSOCIATED WITH PRESCRIPTION OF RIBAVIRIN >800 MG/DAY AMONG G2/3 PATIENTS PRESCRIBED PEGINTERFERON ALFA-2A (40KD) FROM REAL-WORLD PATIENT COHORTS: INTERIM RESULTS FROM PROPHESYS

✍ Scribed by M.L. Shiffman; P. Ferenci; T. Hassanein; M. Curescu; C. Coppola; J. Pruthi; R. Aires; G. Lengyel; S. Pol; D. Nelson; D. Messinger; A. Tietz; G.M. Dusheiko

• Book ID: 117378385
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 115 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(10)60301-7